Paul Austin advocates for increased government funding of psychedelic therapy research, which can transform the way we understand and treat mental health conditions.
Erika Dyck describes how the recent surge in psychedelic research presents opportunities to rethink how we do science, and how we measure the impact of science.
Chelsea Cox explores the financial and ethical implications of Canada’s upcoming legalization of marijuana.
Jean-Christophe Bélisle-Pipon calls attention to issues of accessibility and transparency related to the collection and sale of physician prescribing data by data solution companies.
Steve Morgan gives us four reasons to support universal pharmacare and then invites us to sign the Parliamentary Petition e-959 (Health care services).